Clarify the Role of Veozah for Hot Flashes

July 2023

Veozah (fezolinetant) will be a new nonhormonal med for managing moderate to severe hot flashes during menopause.

It’s the first neurokinin 3 antagonist. It blocks neurokinin B, a chemical that regulates temperature...decreasing vasomotor symptoms.

Tell patients to expect a benefit of about 2 or 3 fewer hot flashes per day with Veozah 45 mg po once daily compared to placebo.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote